0000950172-24-000045.txt : 20240313 0000950172-24-000045.hdr.sgml : 20240313 20240313164216 ACCESSION NUMBER: 0000950172-24-000045 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240313 DATE AS OF CHANGE: 20240313 EFFECTIVENESS DATE: 20240313 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Applied Therapeutics, Inc. CENTRAL INDEX KEY: 0001697532 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-507505 FILM NUMBER: 24746565 BUSINESS ADDRESS: STREET 1: 545 FIFTH AVENUE, SUITE 1400 CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 212-220-9226 MAIL ADDRESS: STREET 1: 545 FIFTH AVENUE, SUITE 1400 CITY: NEW YORK STATE: NY ZIP: 10017 FORMER COMPANY: FORMER CONFORMED NAME: Applied Therapeutics Inc. DATE OF NAME CHANGE: 20170208 D 1 primary_doc.xml X0708 D LIVE 0001697532 Applied Therapeutics, Inc. 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY NEW YORK 10017 212-220-9226 DELAWARE Applied Therapeutics Inc. Corporation true Shoshana Shendelman 545 Fifth Avenue, Suite 1400 New York NY NEW YORK 10017 Executive Officer Director President and Chief Executive Officer Riccardo Perfetti 545 Fifth Avenue, Suite 1400 New York NY NEW YORK 10017 Executive Officer Chief Medical Officer Adam Hansard 545 Fifth Avenue, Suite 1400 New York NY NEW YORK 10017 Executive Officer Chief Commercial Officer Les Funtleyder 545 Fifth Avenue, Suite 1400 New York NY NEW YORK 10017 Executive Officer Director Chief Financial Officer and Director Catherine Thorpe 545 Fifth Avenue, Suite 1400 New York NY NEW YORK 10017 Executive Officer Chief Accounting Officer Stacy J. Kanter 545 Fifth Avenue, Suite 1400 New York NY NEW YORK 10017 Director Teena Lerner 545 Fifth Avenue, Suite 1400 New York NY NEW YORK 10017 Director Joel S. Marcus 545 Fifth Avenue, Suite 1400 New York NY NEW YORK 10017 Director Jay S. Skyler 545 Fifth Avenue, Suite 1400 New York NY NEW YORK 10017 Director Biotechnology Decline to Disclose 06b false 2024-02-27 false true true false 0 UBS Securities LLC 7654 None None 1285 Avenue of the Americas New York NY NEW YORK 10019 CA CALIFORNIA CO COLORADO CT CONNECTICUT FL FLORIDA IL ILLINOIS MD MARYLAND MA MASSACHUSETTS NJ NEW JERSEY NY NEW YORK PA PENNSYLVANIA UT UTAH false Leerink Partners LLC 39011 None None 53 State Street, 40th Floor Boston MA MASSACHUSETTS 02109 CA CALIFORNIA CO COLORADO CT CONNECTICUT FL FLORIDA IL ILLINOIS MD MARYLAND MA MASSACHUSETTS NJ NEW JERSEY NY NEW YORK PA PENNSYLVANIA UT UTAH false RBC Capital Markets, LLC 31194 None None 3 World Financial Center 200 Vesey Street New York NY NEW YORK 10281 CA CALIFORNIA CO COLORADO CT CONNECTICUT FL FLORIDA IL ILLINOIS MD MARYLAND MA MASSACHUSETTS NJ NEW JERSEY NY NEW YORK PA PENNSYLVANIA UT UTAH false Robert W. Baird & Co. Inc. 8158 None None 777 E. Wisconsin Avenue Milwaukee WI WISCONSIN 53202 CA CALIFORNIA CO COLORADO CT CONNECTICUT FL FLORIDA IL ILLINOIS MD MARYLAND MA MASSACHUSETTS NJ NEW JERSEY NY NEW YORK PA PENNSYLVANIA UT UTAH false 99997998 99997998 0 false 31 7499850 true 0 0 false Applied Therapeutics, Inc. /s/ Shoshana Shendelman Shoshana Shendelman Chief Executive Officer 2024-03-13